Literature DB >> 20594621

The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE.

Rita J Guerreiro1, Deborah R Gustafson, John Hardy.   

Abstract

Alzheimer's disease (AD) is a complex disorder with a clear genetic component. Three genes have been identified as the cause of early onset familial AD (EOAD). The most common form of the disease, late onset Alzheimer's disease (LOAD), is, however, a sporadic one presenting itself in later stages of life. The genetic component of this late onset form of AD has been the target of a large number of studies, because only one genetic risk factor (APOE4) has been consistently associated with the disease. However, technological advances allow new approaches in the study of complex disorders. In this review, we discuss the new results produced by genome wide association studies, in light of the current knowledge of the complexity of AD genetics. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20594621      PMCID: PMC2980860          DOI: 10.1016/j.neurobiolaging.2010.03.025

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  199 in total

1.  Population stratification confounds genetic association studies among Latinos.

Authors:  Shweta Choudhry; Natasha E Coyle; Hua Tang; Keyan Salari; Denise Lind; Suzanne L Clark; Hui-Ju Tsai; Mariam Naqvi; Angie Phong; Ngim Ung; Henry Matallana; Pedro C Avila; Jesus Casal; Alfonso Torres; Sylvette Nazario; Richard Castro; Natalie C Battle; Eliseo J Perez-Stable; Pui-Yan Kwok; Dean Sheppard; Mark D Shriver; William Rodriguez-Cintron; Neil Risch; Elad Ziv; Esteban Gonzàlez Burchard
Journal:  Hum Genet       Date:  2005-11-08       Impact factor: 4.132

Review 2.  The neuropathological changes associated with normal brain aging.

Authors:  P R Hof; P Glannakopoulos; C Bouras
Journal:  Histol Histopathol       Date:  1996-10       Impact factor: 2.303

3.  Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study.

Authors:  Robert Stewart; Lon R White; Qian-Li Xue; Lenore J Launer
Journal:  Arch Neurol       Date:  2007-01

4.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

5.  Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update.

Authors:  G Raux; L Guyant-Maréchal; C Martin; J Bou; C Penet; A Brice; D Hannequin; T Frebourg; D Campion
Journal:  J Med Genet       Date:  2005-07-20       Impact factor: 6.318

6.  Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system.

Authors:  Robert D Bell; Abhay P Sagare; Alan E Friedman; Gurrinder S Bedi; David M Holtzman; Rashid Deane; Berislav V Zlokovic
Journal:  J Cereb Blood Flow Metab       Date:  2006-11-01       Impact factor: 6.200

7.  Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3.

Authors:  D A Sanan; K H Weisgraber; S J Russell; R W Mahley; D Huang; A Saunders; D Schmechel; T Wisniewski; B Frangione; A D Roses
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

8.  Complement gene expression in human brain: comparison between normal and Alzheimer disease cases.

Authors:  D G Walker; P L McGeer
Journal:  Brain Res Mol Brain Res       Date:  1992-06

9.  Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease.

Authors:  Gary W Beecham; Eden R Martin; Yi-Ju Li; Michael A Slifer; John R Gilbert; Jonathan L Haines; Margaret A Pericak-Vance
Journal:  Am J Hum Genet       Date:  2009-01       Impact factor: 11.025

Review 10.  Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease.

Authors:  Kina Höglund; Kaj Blennow
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

View more
  87 in total

Review 1.  Dissecting Complex and Multifactorial Nature of Alzheimer's Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective.

Authors:  Puneet Talwar; Juhi Sinha; Sandeep Grover; Chitra Rawat; Suman Kushwaha; Rachna Agarwal; Vibha Taneja; Ritushree Kukreti
Journal:  Mol Neurobiol       Date:  2015-09-09       Impact factor: 5.590

Review 2.  Amyloid beta: structure, biology and structure-based therapeutic development.

Authors:  Guo-Fang Chen; Ting-Hai Xu; Yan Yan; Yu-Ren Zhou; Yi Jiang; Karsten Melcher; H Eric Xu
Journal:  Acta Pharmacol Sin       Date:  2017-07-17       Impact factor: 6.150

Review 3.  The role of DNA base excision repair in brain homeostasis and disease.

Authors:  Mansour Akbari; Marya Morevati; Deborah Croteau; Vilhelm A Bohr
Journal:  DNA Repair (Amst)       Date:  2015-05-01

4.  A novel PSEN2 p.Ser175Phe variant in a family with Alzheimer's disease.

Authors:  Gamze Guven; Bedia Samanci; Cagri Gulec; Hasmet Hanagasi; Hakan Gurvit; Ebru Erzurumluoglu Gokalp; Fatih Tepgec; Suleyman Guler; Oya Uyguner; Basar Bilgic
Journal:  Neurol Sci       Date:  2021-04-15       Impact factor: 3.307

Review 5.  Untangling Genetic Risk for Alzheimer's Disease.

Authors:  Anna A Pimenova; Towfique Raj; Alison M Goate
Journal:  Biol Psychiatry       Date:  2017-05-22       Impact factor: 13.382

Review 6.  Genetic diagnosis and prognosis of Alzheimer's disease: challenges and opportunities.

Authors:  Christiane Reitz
Journal:  Expert Rev Mol Diagn       Date:  2015-01-29       Impact factor: 5.225

Review 7.  Targeting Hsp90 and its co-chaperones to treat Alzheimer's disease.

Authors:  Laura J Blair; Jonathan J Sabbagh; Chad A Dickey
Journal:  Expert Opin Ther Targets       Date:  2014-07-29       Impact factor: 6.902

8.  Potential involvement of GRIN2B encoding the NMDA receptor subunit NR2B in the spectrum of Alzheimer's disease.

Authors:  Virginia Andreoli; Elvira Valeria De Marco; Francesca Trecroci; Rita Cittadella; Gemma Di Palma; Antonio Gambardella
Journal:  J Neural Transm (Vienna)       Date:  2013-12-01       Impact factor: 3.575

Review 9.  Inflammatory mediators as biomarkers in brain disorders.

Authors:  Domenico Nuzzo; Pasquale Picone; Luca Caruana; Sonya Vasto; Annalisa Barera; Calogero Caruso; Marta Di Carlo
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

Review 10.  Alzheimer's disease genetics: from the bench to the clinic.

Authors:  Celeste M Karch; Carlos Cruchaga; Alison M Goate
Journal:  Neuron       Date:  2014-07-02       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.